Fiera Capital (Canada)
PDLI

Fiera Capital (Canada)’s PDL BioPharma, Inc. PDLI Stock Holding History

Fiera Capital (Canada)’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-270,700
Closed -$2.62M – 570
2014
Q2 		$2.62M Buy
270,700
+27,800
+11% +$248K 0.01% 303
2014
Q1 		$2.02M Buy
242,900
+12,100
+5% +$104K 0.02% 354
2013
Q4 		$1.95M Buy
230,800
+53,400
+30% +$450K 0.02% 340
2013
Q3 		$1.41M Buy
177,400
+2,700
+2% +$21.7K 0.01% 287
2013
Q2 		$1.35M Buy
+174,700
New +$1.36M 0.01% 288

Other funds holding PDLI

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Advisors Asset Management
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fiera Capital (Canada)'s PDLI Position: Q3 2014 in Review

Fiera Capital (Canada) sold out of PDL BioPharma, Inc. (PDLI) in Q3 2014, closing a stake of 270,700 shares — an estimated $2.62M sold.

Fiera Capital (Canada) first reported a position in PDLI in Q2 2013 and held it in 5 quarters. The position peaked at $2.62M in Q2 2014. 231 funds tracked by Wall St. Rank hold PDLI as of Q3 2014.

  • Fiera Capital (Canada) reported no remaining PDL BioPharma, Inc. position as of Q3 2014 after selling out during the quarter.
  • Fiera Capital (Canada) sold 270,700 PDL BioPharma, Inc. shares in Q3 2014, an estimated $2.62M.
  • Fiera Capital (Canada) first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 5 quarters.
  • Fiera Capital (Canada)'s PDL BioPharma, Inc. position peaked at $2.62M in Q2 2014.
  • 231 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2014.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2014, filed 17 Nov 2014.